Loading...
Insight into Metabolic (1)H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions
BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is a severe complication of immunosuppressive therapies, especially of natalizumab in relapsing–remitting multiple sclerosis (MS). Metabolic changes within PML lesions have not yet been described in natalizumab-associated PML in MS patient...
Na minha lista:
| Udgivet i: | Front Neurol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5591840/ https://ncbi.nlm.nih.gov/pubmed/28928709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2017.00454 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|